Graham Capital Management, L.P. Insmed Inc Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $173,944 - $202,484	6,763 Added 59.81%	18,071 $490,000
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $756,395 - $1.03 Million	-32,297 Reduced 74.07%	11,308 $350,000
Q3 2023 Nov 22, 2023	BUY	$19.86 - $26.93 $674,624 - $914,785	33,969 Added 352.52%	43,605 $1.1 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $158,415 - $203,319	9,636 New	9,636 $203,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $1.95 Million - $2.64 Million	93,440 New	93,440 $2.01 Million

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.